← Open Payments lookup

CURTIS CHILD: Open Payments

NPI 1144327099 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$865 in 45 payments from 10 companies in 2025. Trend: 2023 $937 · 2024 $632 · 2025 $865

Food & beverage: $865
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$347
Neurocrine BioSciences, Inc.6$114
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$98
Lundbeck LLC4$66
E.R. Squibb & Sons, L.L.C.3$62
Alkermes, Inc.3$57
Vanda Pharmaceuticals Inc.2$52
ABBVIE INC.2$36
Janssen Pharmaceuticals, Inc1$17
Teva Pharmaceuticals USA, Inc.1$16

Products named: ABILIFY ASIMTUFII, REXULTI, INGREZZA, CAPLYTA, COBENFY, FANAPT, LYBALVI, VRAYLAR.

Industry payments across NV — which companies pay providers there.